Provided by Tiger Trade Technology Pte. Ltd.

Splash Beverage Group Inc.

0.4715
+0.046510.94%
Post-market: 0.4201-0.0514-10.90%19:59 EDT
Volume:1.62M
Turnover:750.33K
Market Cap:2.97M
PE:-0.01
High:0.4744
Open:0.4408
Low:0.4403
Close:0.4250
52wk High:13.40
52wk Low:0.2500
Shares:6.30M
Float Shares:6.30M
Volume Ratio:2.35
T/O Rate:25.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-34.9121
EPS(LYR):-70.9984
ROE:-1130.20%
ROA:-77.00%
PB:-0.19
PE(LYR):-0.01

Loading ...

Splash Beverage Group Rebrands as Endovia Health Sciences, Adopts NYSE American Ticker EDVA

Reuters
·
Aug 21

Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences

Reuters
·
Aug 20

Endovia Health Sciences Narrows FY26 H1 Operating Loss 64% to $4 Million

Reuters
·
Aug 20

Splash Beverage Group Q2 EPS $(0.77) Up From $(17.88) YoY, Sales $0.00, Same YoY

Benzinga Earnings
·
Aug 20

Splash Beverage Group Delays Q2 10-Q Filing Citing Limited Resources

Reuters
·
Aug 17

Splash Beverage Group - Company to Adopt New Ticker Symbol Edva and Launch Endoviasciences.com - SEC Filing

THOMSON REUTERS
·
Aug 12

Splash Beverage Group - to Change Name to Endovia Health Sciences Effective August 24, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 12

Splash Beverage to Rebrand as Endovia Health Sciences, Adopt EDVA Ticker Aug. 24

Reuters
·
Aug 12

Splash Beverage Group: Files Prospectus for Resale of up to 5,000,000 Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Aug 08

Splash Beverage Group Inc: Retains Ownership of Resulting Data, Intellectual Property and Commercialization Rights

THOMSON REUTERS
·
Aug 05

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance Cannepil® Through FDA Veterinary Pathway

THOMSON REUTERS
·
Aug 05

Splash Beverage Partners with Lupvindol to Develop CannEpil-Based Veterinary Drug for FDA Conditional Approval

Reuters
·
Aug 05

Splash Beverage Group - Lupvindol to Lead Development and FDA Regulatory Activities for Animal Drug from Cannepil - SEC Filing

THOMSON REUTERS
·
Aug 05

Splash Beverage Group - Collaboration Agreement Has Initial Five-Year Term - SEC Filing

THOMSON REUTERS
·
Aug 05

Splash Beverage Expands CannEpil License to Veterinary Therapeutics in 8-K Amendment

Reuters
·
Jul 31

Splash Beverage Group - Expands Cannepil License to Veterinary Therapeutics

THOMSON REUTERS
·
Jul 29

Splash Beverage Finalizes Joint Venture with Cannabinoid Pharma Group for CannEpil Veterinary Program

Reuters
·
Jul 29

Splash Beverage Extends Investor Settlement Payment Deadline, Sets July 31 Due Date for $137,797.54 at 12% Interest

Reuters
·
Jul 22

Splash Beverage Group - Amends Settlement Agreements with Three Prior Investors on July 15, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 22

Splash Beverage Group Sets 1-for-4 Reverse Stock Split Effective July 24

Reuters
·
Jul 14